
|Articles|July 27, 2020
Adenovirus COVID-19 Vaccines: Challenges of Prior AD Immunity
Author(s)Grant M. Gallagher
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.
Advertisement
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the
Dr. Soon-Shiong delves into some of his reasoning for the ImmunityBio vaccine candidate's particular orientation toward the immune system.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
2
Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Post-Antibiotic Era
3
One Third of Chronic Hepatitis B Patients Are Lost to Follow-Up
4
DOOR Analysis Shows Antibiotic Matches Standard Therapy in Effectiveness
5